Intuitive Surgical, Inc. (ISRG) Gross Margin
- Gross margin · 12 months: Value 66.68%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 66.68% | Gross profit / revenue. Period ending 2026-06-30. $7.36B ÷ $11.03B × 100 ≈ 66.68% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 7.36B USD | Gross Profit |
| Revenue | 11.03B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 3.68B USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $7.36B | $11.03B | $3.68B | 66.68% |
| 2026-03-31 | $7.02B | $10.58B | $3.57B | 66.29% |
| 2025-12-31 | $6.64B | $10.06B | $3.42B | 66.00% |
| 2025-09-30 | $6.38B | $9.61B | $3.23B | 66.38% |
| 2025-06-30 | $6.09B | $9.14B | $3.05B | 66.61% |
| 2025-03-31 | $5.85B | $8.71B | $2.87B | 67.09% |
| 2024-12-31 | $5.63B | $8.35B | $2.72B | 67.46% |
| 2024-09-30 | $5.27B | $7.87B | $2.60B | 66.98% |
| 2024-06-30 | $5.06B | $7.57B | $2.51B | 66.86% |
| 2024-03-31 | $4.86B | $7.32B | $2.46B | 66.43% |
| 2023-12-31 | $4.73B | $7.12B | $2.39B | 66.39% |
| 2023-09-30 | $4.56B | $6.85B | $2.29B | 66.61% |
| 2023-06-30 | $4.45B | $6.66B | $2.22B | 66.74% |
| 2023-03-31 | $4.30B | $6.43B | $2.13B | 66.86% |
| 2022-12-31 | $4.20B | $6.22B | $2.03B | 67.44% |
| 2022-09-30 | $4.15B | $6.12B | $1.97B | 67.77% |
| 2022-06-30 | $4.07B | $5.96B | $1.90B | 68.16% |
| 2022-03-31 | $4.07B | $5.91B | $1.84B | 68.84% |
| 2021-12-31 | $3.96B | $5.71B | $1.75B | 69.32% |
| 2021-09-30 | $3.79B | $5.49B | $1.70B | 69.12% |
| 2021-06-30 | $3.55B | $5.16B | $1.62B | 68.69% |
| 2021-03-31 | $3.03B | $4.55B | $1.53B | 66.48% |
| 2020-12-31 | $2.86B | $4.36B | $1.50B | 65.65% |
| 2020-09-30 | $2.86B | $4.31B | $1.45B | 66.44% |
| 2020-06-30 | $2.92B | $4.36B | $1.43B | 67.07% |
| 2020-03-31 | $3.18B | $4.60B | $1.43B | 69.04% |
| 2019-12-31 | $3.11B | $4.48B | $1.37B | 69.45% |
| 2019-09-30 | $2.95B | $4.25B | $1.30B | 69.45% |
| 2019-06-30 | $2.81B | $4.04B | $1.23B | 69.47% |
| 2019-03-31 | $2.68B | $3.85B | $1.17B | 69.60% |
| 2018-12-31 | $2.60B | $3.72B | $1.12B | 69.92% |
| 2018-09-30 | $2.49B | $3.56B | (m) | 70.06% |
| 2018-06-30 | $2.42B | $3.45B | (m) | 70.21% |
| 2018-03-31 | $2.32B | $3.30B | (m) | 70.31% |
| 2017-12-31 | $2.19B | $3.13B | (m) | 70.12% |
| 2017-09-30 | $2.09B | $2.99B | (m) | 69.75% |
| 2017-06-30 | $2.01B | $2.87B | (m) | 69.97% |
| 2017-03-31 | $1.95B | $2.78B | (m) | 70.08% |
| 2016-12-31 | $1.89B | $2.70B | (m) | 69.89% |
| 2016-09-30 | $1.82B | $2.62B | (m) | 69.42% |
| 2016-06-30 | $1.73B | $2.53B | (m) | 68.38% |
| 2016-03-31 | $1.65B | $2.45B | (m) | 67.28% |
| 2015-12-31 | $1.58B | $2.38B | (m) | 66.18% |
| 2015-09-30 | $1.51B | $2.31B | (m) | 65.40% |
| 2015-06-30 | $1.48B | $2.27B | (m) | 64.99% |
| 2015-03-31 | $1.44B | $2.20B | (m) | 65.26% |
| 2014-12-31 | $1.41B | $2.13B | (m) | 66.32% |
| 2014-09-30 | $1.42B | $2.10B | (m) | 67.44% |
| 2014-06-30 | $1.41B | $2.05B | (m) | 68.93% |
| 2014-03-31 | $1.48B | $2.12B | (m) | 69.64% |
| 2013-12-31 | $1.59B | $2.27B | (m) | 70.38% |
| 2013-09-30 | $1.63B | $2.30B | (m) | 71.10% |
| 2013-06-30 | $1.67B | $2.34B | (m) | 71.35% |
| 2013-03-31 | $1.65B | $2.29B | (m) | 71.84% |
| 2012-12-31 | $1.57B | $2.18B | (m) | 72.07% |
| 2012-09-30 | $1.50B | $2.07B | (m) | 72.37% |
| 2012-06-30 | $1.43B | $1.98B | (m) | 72.43% |
| 2012-03-31 | $1.35B | $1.86B | (m) | 72.46% |
| 2011-12-31 | $1.27B | $1.76B | (m) | 72.49% |
| 2011-09-30 | $1.19B | $1.65B | (m) | 72.31% |
| 2011-06-30 | $1.12B | $1.55B | (m) | 72.25% |
| 2011-03-31 | $1.07B | $1.47B | (m) | 72.55% |
| 2010-12-31 | $1.03B | $1.41B | (m) | 72.89% |
| 2010-09-30 | $981.05M | $1.35B | (m) | 72.84% |
| 2010-06-30 | $929.45M | $1.28B | (m) | 72.47% |
| 2010-03-31 | $862.85M | $1.19B | (m) | 72.36% |
| 2009-12-31 | $751.05M | $1.05B | (m) | 71.38% |
| 2009-09-30 | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) |
| 2008-12-31 | $620.78M | $874.92M | (m) | 70.95% |
| 2008-09-30 | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) |
| 2007-12-31 | $414.29M | $600.83M | (m) | 68.95% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |